Majority of GNs (97.6%) present sporadically, with the remainder associated with genetic syndromes such as neurofibromatosis type 1 (NF1) and type 2 (NF2), and multiple endocrine neoplasia type 2 (MEN 2) [4, 5]. Here, NF2 is linked to neurofibromatosis type 1.